{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:12:32Z","timestamp":1740147152356,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T00:00:00Z","timestamp":1612742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009602","name":"Howard and Georgeanna Jones Foundation for Reproductive Medicine","doi-asserted-by":"publisher","award":["850305"],"award-info":[{"award-number":["850305"]}],"id":[{"id":"10.13039\/100009602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s43032-020-00433-x","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T22:52:05Z","timestamp":1612911125000},"page":"1974-1980","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Drospirenone Effects on the Plasminogen Activator System in Immortalized Human Endometrial Endothelial Cells"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4485-2283","authenticated-orcid":false,"given":"Reem","family":"Sabouni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Jacot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,8]]},"reference":[{"key":"433_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ajog.2016.12.008","volume":"216","author":"RE Zigler","year":"2017","unstructured":"Zigler RE, McNicholas C. Unscheduled vaginal bleeding with progestin-only contraceptive use. Am J Obstet Gynecol. 2017;216:443\u201350.","journal-title":"Am J Obstet Gynecol"},{"key":"433_CR2","doi-asserted-by":"publisher","first-page":"d6423","DOI":"10.1136\/bmj.d6423","volume":"343","author":"O Lidegaard","year":"2011","unstructured":"Lidegaard O, Nielsen LH, Skovlund CW, Skjeldestad FE, Lokkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ. 2011;343:d6423.","journal-title":"BMJ"},{"key":"433_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10456-005-9003-z","volume":"8","author":"OP Smith","year":"2005","unstructured":"Smith OP, Critchley HO. Progestogen only contraception and endometrial break through bleeding. Angiogenesis. 2005;8:117\u201326.","journal-title":"Angiogenesis"},{"key":"433_CR4","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/gme.0b013e31820bf288","volume":"18","author":"CJ Lockwood","year":"2011","unstructured":"Lockwood CJ. Mechanisms of normal and abnormal endometrial bleeding. Menopause. 2011;18:408\u201311.","journal-title":"Menopause"},{"key":"433_CR5","doi-asserted-by":"crossref","unstructured":"Urano T, Castellino FJ, Suzuki Y. Regulation of plasminogen activation on cell surfaces and fibrin. J Thromb Haemost. 2018.","DOI":"10.1111\/jth.14157"},{"key":"433_CR6","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","volume":"28","author":"M Cesari","year":"2010","unstructured":"Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther. 2010;28:e72\u201391.","journal-title":"Cardiovasc Ther"},{"key":"433_CR7","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1067\/mob.2001.113851","volume":"184","author":"CJ Lockwood","year":"2001","unstructured":"Lockwood CJ. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells. Am J Obstet Gynecol. 2001;184:798\u2013804 discussion \u22125.","journal-title":"Am J Obstet Gynecol"},{"key":"433_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/00016346609158476","volume":"45","author":"G Rybo","year":"1966","unstructured":"Rybo G. Clinical and experimental studies on menstrual blood loss. Acta Obstet Gynecol Scand. 1966;45:1\u201323.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"433_CR9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1471-0528.1993.tb14272.x","volume":"100","author":"N Gleeson","year":"1993","unstructured":"Gleeson N, Devitt M, Sheppard BL, Bonnar J. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding. Br J Obstet Gynaecol. 1993;100:768\u201371.","journal-title":"Br J Obstet Gynaecol"},{"key":"433_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/0002-9378(94)90466-9","volume":"171","author":"NC Gleeson","year":"1994","unstructured":"Gleeson NC. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia. Am J Obstet Gynecol. 1994;171:178\u201383.","journal-title":"Am J Obstet Gynecol"},{"key":"433_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","volume":"62","author":"R Krattenmacher","year":"2000","unstructured":"Krattenmacher R. Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception. 2000;62:29\u201338.","journal-title":"Contraception"},{"key":"433_CR12","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.104.501502","volume":"112","author":"WB White","year":"2005","unstructured":"White WB, Pitt B, Preston RA, Hanes V. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension. Circulation. 2005;112:1979\u201384.","journal-title":"Circulation"},{"key":"433_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/01.gme.0000243572.63322.f7","volume":"14","author":"RA Preston","year":"2007","unstructured":"Preston RA, Norris PM, Alonso AB, Ni P, Hanes V, Karara AH. Randomized, placebo-controlled trial of the effects of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. Menopause. 2007;14:408\u201314.","journal-title":"Menopause"},{"key":"433_CR14","doi-asserted-by":"crossref","unstructured":"Chen ZW, Tsai CH, Pan CT, Chou CH, Liao CW, Hung CS, et al. Endothelial dysfunction in primary Aldosteronism. Int J Mol Sci. 2019;20.","DOI":"10.3390\/ijms20205214"},{"key":"433_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11906-019-0981-4","volume":"21","author":"JL Faulkner","year":"2019","unstructured":"Faulkner JL, Belin de Chantemele EJ. Mineralocorticoid Receptor and Endothelial Dysfunction in Hypertension. Curr Hypertens Rep. 2019;21:78.","journal-title":"Curr Hypertens Rep"},{"key":"433_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/13697130802403994","volume":"12","author":"H Seeger","year":"2009","unstructured":"Seeger H, Wallwiener D, Mueck AO. Effects of drospirenone on cardiovascular markers in human aortic endothelial cells. Climacteric. 2009;12:80\u20137.","journal-title":"Climacteric"},{"key":"433_CR17","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1177\/1933719116645193","volume":"23","author":"T Pakrashi","year":"2016","unstructured":"Pakrashi T, Taylor JE, Nelson A, Archer DF, Jacot T. The effect of levonorgestrel on fibrinolytic factors in human endometrial endothelial cells. Reprod Sci. 2016;23:1536\u201341.","journal-title":"Reprod Sci"},{"key":"433_CR18","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S0015-0282(00)00489-1","volume":"73","author":"E Rutanen","year":"2000","unstructured":"Rutanen E, Hurskainen R, Finne P, Nokelainen K. Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia. Fertil Steril. 2000;73:1020\u20134.","journal-title":"Fertil Steril"},{"key":"433_CR19","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1111\/aogs.13688","volume":"98","author":"S Palacios","year":"2019","unstructured":"Palacios S, Colli E, Regidor PA. Multicenter, phase III trials on the contraceptive efficacy, tolerability and safety of a new drospirenone-only pill. Acta Obstet Gynecol Scand. 2019;98:1549\u201357.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"433_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.contraception.2015.07.014","volume":"92","author":"DF Archer","year":"2015","unstructured":"Archer DF, Ahrendt HJ, Drouin D. Drospirenone-only oral contraceptive: results from a multicenter noncomparative trial of efficacy, safety and tolerability. Contraception. 2015;92:439\u201344.","journal-title":"Contraception"},{"key":"433_CR21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0303-7207(86)90132-2","volume":"44","author":"J Simard","year":"1986","unstructured":"Simard J, Luthy I, Guay J, Belanger A, Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol. 1986;44:261\u201370.","journal-title":"Mol Cell Endocrinol"},{"key":"433_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","volume":"54","author":"U Fuhrmann","year":"1996","unstructured":"Fuhrmann U, Krattenmacher R, Slater EP, Fritzemeier KH. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Contraception. 1996;54:243\u201351.","journal-title":"Contraception"},{"key":"433_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0010-7824(94)00015-O","volume":"51","author":"P Muhn","year":"1995","unstructured":"Muhn P, Krattenmacher R, Beier S, Elger W, Schillinger E. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models. Contraception. 1995;51:99\u2013110.","journal-title":"Contraception"},{"key":"433_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bbrc.2017.07.063","volume":"491","author":"R Louw-du Toit","year":"2017","unstructured":"Louw-du Toit R, Perkins MS, Hapgood JP, Africander D. Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy. Biochem Biophys Res Commun. 2017;491:140\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"433_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mce.2017.10.006","volume":"465","author":"K Takov","year":"2018","unstructured":"Takov K, Wu J, Denvir MA, Smith LB, Hadoke PWF. The role of androgen receptors in atherosclerosis. Mol Cell Endocrinol. 2018;465:82\u201391.","journal-title":"Mol Cell Endocrinol"},{"key":"433_CR26","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1161\/01.CIR.99.17.2317","volume":"99","author":"JA McCrohon","year":"1999","unstructured":"McCrohon JA, Jessup W, Handelsman DJ, Celermajer DS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation. 1999;99:2317\u201322.","journal-title":"Circulation"},{"key":"433_CR27","first-page":"647","volume":"118","author":"S Chang","year":"2018","unstructured":"Chang S, Rasmussen JJ, Frandsen MN, Schou M, Johansen ML, Faber J, et al. Procoagulant state in current and former anabolic androgenic steroid abusers. Thromb Haemost. 2018;118:647\u201353.","journal-title":"Thromb Haemost"},{"key":"433_CR28","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1139\/O07-011","volume":"85","author":"H Jin","year":"2007","unstructured":"Jin H, Lin J, Fu L, Mei YF, Peng G, Tan X, et al. Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells. Biochem Cell Biol. 2007;85:246\u201351.","journal-title":"Biochem Cell Biol"},{"key":"433_CR29","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1093\/humrep\/deg510","volume":"18","author":"KA Burton","year":"2003","unstructured":"Burton KA, Henderson TA, Hillier SG, Mason JI, Habib F, Brenner RM, et al. Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium. Hum Reprod. 2003;18:2610\u20137.","journal-title":"Hum Reprod"},{"key":"433_CR30","doi-asserted-by":"publisher","first-page":"T67","DOI":"10.1530\/JOE-17-0009","volume":"234","author":"JJ DuPont","year":"2017","unstructured":"DuPont JJ, Jaffe IZ. 30 years of the mineralocorticoid receptor: the role of the mineralocorticoid receptor in the vasculature. J Endocrinol. 2017;234:T67\u201382.","journal-title":"J Endocrinol"},{"key":"433_CR31","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/S0021-9258(19)81690-3","volume":"264","author":"J Wojta","year":"1989","unstructured":"Wojta J, Hoover RL, Daniel TO. Vascular origin determines plasminogen activator expression in human endothelial cells. Renal endothelial cells produce large amounts of single chain urokinase type plasminogen activator. J Biol Chem. 1989;264:2846\u201352.","journal-title":"J Biol Chem"},{"key":"433_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jss.2014.09.028","volume":"194","author":"NG Kumar","year":"2015","unstructured":"Kumar NG, Clark A, Roztocil E, Caliste X, Gillespie DL, Cullen JP. Fibrinolytic activity of endothelial cells from different venous beds. J Surg Res. 2015;194:297\u2013303.","journal-title":"J Surg Res"},{"key":"433_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jss.2017.12.017","volume":"225","author":"BR Huebner","year":"2018","unstructured":"Huebner BR, Moore EE, Moore HB, Gonzalez E, Kelher MR, Sauaia A, et al. Thrombin stimulates increased plasminogen activator inhibitor-1 release from liver compared to lung endothelium. J Surg Res. 2018;225:1\u20135.","journal-title":"J Surg Res"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-020-00433-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-020-00433-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-020-00433-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T20:22:45Z","timestamp":1623270165000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-020-00433-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,8]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["433"],"URL":"https:\/\/doi.org\/10.1007\/s43032-020-00433-x","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"type":"print","value":"1933-7191"},{"type":"electronic","value":"1933-7205"}],"subject":[],"published":{"date-parts":[[2021,2,8]]},"assertion":[{"value":"23 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}]}}